Category: Biomarker

November 2, 2023

The American Cancer Society (ACS) has announced new guidelines for lung cancer screenings. Published in the ACS journal “CA: A Cancer Journal for Clinicians” on Wednesday, the advisory reconsiders those who are at high risk for developing lung cancer and […]

October 30, 2023

Upfront Diagnostics has embarked on the final phase of clinical trials in UK hospitals evaluating the use of its point-of-care rapid blood test for stroke. The clinical study is being led by the Newcastle University Stroke Research Group in the […]

October 26, 2023

We are living in a mental health epidemic. An estimated 26 percent of Americans ages 18 and older – about one in four adults – suffer from a diagnosable mental disorder in a given year. Among mental disorders, cases of […]

October 18, 2023

It’s that time of year again. Upper respiratory infections like respiratory syncytial virus (RSV), influenza and COVID are rising — and we’re only just getting started. The signs and symptoms of these infections can be quite similar and include anything […]

October 12, 2023

Shanghai Kehua Bio-engineering (KHB) has obtained an EU class D in vitro diagnostic regulation certification for rapid tests covering the company’s diagnostic kit for HIV (1/2) antibody (Colloidal Gold) V2. KHB’s HIV diagnostic kit tests for human immunodeficiency virus (HIV)-1 […]

October 9, 2023

As the prevalence of neurodegenerative diseases rapidly rises, researchers at the ongoing HLTH 2023 conference highlighted how biomarker development is urgently needed for treatment breakthroughs to occur. In the United States, as many as 6.2 million people may have Alzheimer’s […]

August 11, 2023

By summer 2021, Gilbert Milam Jr. was living a good life. A nationally renowned rapper who performs under the name Berner, Milam was also enjoying the global expansion of Cookies, a brand of cannabis products and clothing that he co-founded […]

August 1, 2023

An estimated 10-20% of adolescents struggle with mental health conditions, with the majority remaining undiagnosed and untreated. New, early indicators of mental health problems are urgently needed, as they could revolutionize early detection and, in the future, the prevention of […]

July 18, 2023

Hot on the heels of positive results for Eli Lilly’s Alzheimer’s disease (AD) drug donanemab, a new blood-based test could soon be hitting the AD clinical space. The Alzheimer’s Drug Discovery Foundation (ADDF) has seen the clinical promise in ALZpath’s […]

July 7, 2023

Quanterix has introduced the new biomarker blood test, LucentAD, to facilitate the diagnosis of Alzheimer’s disease (AD) in patients. The test has been designed to help assess patients experiencing cognitive symptoms consistent with the early signs of AD. Healthcare providers […]

June 22, 2023

In GlobalData’s Clinical Trials Database, there are currently 1,490 active clinical trials for in vitro diagnostics (IVD) devices, where 569 trials are focused on oncology diagnostic devices. Specifically, nine of these trials involve analysis or partial analysis. This month, Mindpeak, […]

June 21, 2023

Lung cancer is the leading cause of cancer deaths worldwide, with approximately 1.8 million people dying from this disease each year. Most patients are diagnosed after symptoms have appeared and the disease has progressed to an advanced stage (Stage III […]

June 14, 2023

Biotech company Heligenics has introduced a new precision genetic test to choose among drugs for the treatment of breast cancer. The new genetic test helps select among three drugs approved by the US Food and Drug Administration (FDA) for breast […]

May 12, 2023

Aspira Women’s Health has entered an exclusive licensing deal with the Dana-Farber Cancer Institute (DFCI) to design and develop a new microRNA-based ovarian cancer diagnostic test. The new test will use circulating microRNAs, either alone or along with proteins or […]

May 9, 2023

The U.S. Preventive Services Task Force (USPSTF), based in Rockdale, Maryland, has released a draft of new guidelines for breast cancer screenings, recommending that women begin getting mammograms every other year starting at the age of 40. The new guidelines […]

May 2, 2023

Tempus has received premarket approval from the US Food and Drug Administration (FDA) for its qualitative next-generation sequencing (NGS)-based in vitro diagnostic device, xT CDx. The xT CDx device is designed to detect substitutions (single nucleotide variants and multi-nucleotide variants), […]

April 27, 2023

CND Life Sciences has announced that its Syn-One Test was able to identify the pathological form of alpha-synuclein in the skin of more than 95% of patients diagnosed with synucleinopathy in the Synuclein-One study. Synucleinopathies are a group of disorders […]

April 13, 2023

An international group of researchers has discovered a new tool that can reveal a key pathology of Parkinson’s disease in brain and body cells. The identification of the new biomarker, known as abnormal alpha-synuclein, opens a new chapter for research, […]

April 10, 2023

Genomic diagnostics company GC Genome has announced the results of a study that proved the ability of its liquid biopsy technology to predict radiation therapy (RT) response in solid tumours. The trial showed the feasibility of cell-free DNA (cfDNA) monitoring […]

March 29, 2023

The Roddenberry Foundation has awarded $1m to Elypta and $500,000 to five finalists for early-stage ventures contributing to United Nations Development Goals. Elypta, a Swedish diagnostic company, aim to provide the first metabolism-based liquid biopsy for early detection of cancer. […]